Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization

By Doctor Priyanka   Bhat Pooja   Sayed Reema   Foster C. Stephen  

Ocular Immunology and Inflammation, Vol. 17, Iss. 2, 2009-04 ,pp. : 118-126

Informa Healthcare

Access to resources Recommend Favorite

Juxtafoveal Choroidal Neovascularization Secondary to Persistent Placoid Maculopathy Treated with Intravitreal Bevacizumab

By Parodi Maurizio Battaglia   Iacono Pierluigi   Bandello Francesco  

Ocular Immunology and Inflammation, Vol. 18, Iss. 5, 2010-10 ,pp. : 399-401

Informa Healthcare

Access to resources Recommend Favorite

Prostaglandin E 1 inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cells

By Dell K.   Bohler T.   Gaedeke J.   Budde K.   Neumayer H.-H.   Waiser J.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3342-3344

Elsevier

Access to resources Recommend Favorite

Targeting Tissue Factor for Immunotherapy of Choroidal Neovascularization by Intravitreal Delivery of Factor VII-Fc Chimeric Antibody

By Tezel Tongalp   Bodek Ewa   Sönmez Kenan   Kaliappan Sankar   Kaplan Henry   Hu Zhiwei   Garen Alan  

Ocular Immunology and Inflammation, Vol. 15, Iss. 1, 2007-01 ,pp. : 3-10

Informa Healthcare

Access to resources Recommend Favorite

Brequinar in combination with cyclosporine a inhibits islet xenograft rejection for up to 24 days: a study in the pig-to-rat model

By Wennberg L.   Song Z.   Wijkstrom M.   Zhang J.   Bari S.   Sundberg B.   Groth C.G.   Korsgren O.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 1026-1026

Elsevier

Access to resources Recommend Favorite